Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04629586 · ClinicalTrials.gov registry record
The T1D Exchange Registry
A clinical trial of Diabetes and Diabetes Mellitus, sponsored by T1D Exchange, United States.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 1
- Study location
NCT04629586: Recruiting study of Diabetes and Diabetes Mellitus, sponsored by T1D Exchange, United States.
NCT04629586 is a study of Diabetes and Diabetes Mellitus that is actively recruiting participants, run by T1D Exchange, United States. The registered enrollment target is 50,000 participants, above the 2,880-participant average among 338 other Diabetes trials with a reported enrollment target (1636% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04629586, a study of Diabetes and Diabetes Mellitus, is actively recruiting participants, sponsored by T1D Exchange, United States.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes. To participate, you will be asked to: * Read and sign an online informed consent form * Take a survey describing specific demographic and type 1 diabetes management information * Update your information annually * Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data
Primary Outcome
Gather longitudinal data on disease, health status, and patient-reported outcomes of individuals living with type 1 diabetes. This will be achieved by presenting participants with annual questionnaires, tracking any changes in their responses over time.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Massachusetts
- T1D Exchange - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2018-12-13 |
| Est. Completion | 2030-12-31 |
What NCT04629586 shows while recruiting
NCT04629586 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,880-participant average among 338 other Diabetes trials with a reported enrollment target (1636% higher).
The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT04629586 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04629586 about?
NCT04629586 is a clinical study titled "The T1D Exchange Registry". The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity ...
What is the current status of trial NCT04629586?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2018-12-13. Estimated completion is 2030-12-31.
What conditions does trial NCT04629586 study?
This clinical trial studies the following conditions: Diabetes, Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT04629586?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04629586?
This trial is sponsored by T1D Exchange, United States, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04629586 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04629586's enrollment target sits among peer trials
50,000 6th of 338 higher than 333 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT05497518 · 50,000 participants
The KidneyCARE (Community Access to Research Equity) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI